News & Media

Pfizer's $101-billion move on AstraZeneca

Easter weekend has seen the rumour mill go into overdrive with reports that drug giant Pfizer has made advances on Anglo-Swedish drugmaker AstraZeneca.

Click here for the article.
 

Back

Subscribe to the BAM Newsletter

Sign up for one of BAM's newsletter to learn more about bioscience, happenings in Manitoba's bioeconomy, industry conferences, and BAM training events.

Subscribe